Usual and unusual agranulocytosis during neuroleptic therapy.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008728:Methotrimeprazine / Q000009:adverse effects; D008875:Middle Aged; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014149:Tranquilizing Agents; D008728:Methotrimeprazine